Editorial Disclosure: GLP-1 Editorial is an editorial publication operated by Ranika Editorial Group LLC. We do not provide medical care, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment. Our rankings are based on our published v3.0 transparency rubric, publicly available provider information, cited sources, and periodic review updates. If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page and at /affiliate-disclosure.html.
Last reviewed: May 31, 2026
Next scheduled review: June 30, 2026
Reviewed by: Dr. Sam Saberian, Lead Medical Researcher
The only provider in our directory that publishes against all six transparency pillars for semaglutide. Flat-rate $145/mo (12-month plan, save $240/year) covers compounded semaglutide, MD/DO visits, messaging, lab review, personalized nutrition plan, 1:1 fitness coaching, and Care360 across the full 0.25-2.4 mg titration. Klarna and Afterpay financing accepted.
#1 of 1094/100$145-$165/mo
SS
Editorial team
Dr. Sam Saberian · Lead Medical Researcher
Medical review by Alen A. Schwartz, MD · Edited by Julliana Edwards · Last updated 2026-06-10
Editor's Pick · #1 of 10
NexLife — Compounded Semaglutide
✨ Editor's Pick · 94/100
💊 Compounded semaglutide + tirzepatide
👨⚕️ MD/DO-supervised
🏥 503A & 503B pharmacies
🧪 Labs included
📍 Availability varies by state
✓ LegitScript-certified
💰 Flat-rate, dose-independent
🔁 Care360 + 1:1 fitness coaching
🍽️ Personalized nutrition plan
💳 Klarna & Afterpay accepted
$145/ month*
*12-month plan · save $240/yr · flat rate across full 0.25–2.4 mg titration. $147 (6-mo, save $108) · $149 (3-mo, save $48) · $165 (monthly).
Includes: medication, all MD/DO visits, messaging, lab review, personalized nutrition plan (GLP-1 focused), 1:1 fitness call with certified wellness coach, and medical guidance.
Compounded only — no brand-name Wegovy® / Ozempic® / Rybelsus®. Cash-pay with HSA/FSA only — no in-network insurance billing. Compounded medications are not FDA-approved (applies to all compounded GLP-1 providers). Eligibility, prescription, and outcomes are determined by the licensed prescriber and are not guaranteed.
Editor's Pick · #1 of 10 · Tirzepatide
NexLife — Compounded Tirzepatide
✨ Editor's Pick · 94/100
💊 Compounded semaglutide + tirzepatide
👨⚕️ MD/DO-supervised
🏥 503A & 503B pharmacies
🧪 Labs included
📍 Availability varies by state
✓ LegitScript-certified
💰 Flat-rate, dose-independent
🔁 Care360 coaching
📱 Apple Health / Google Fit sync
$186/ month*
*12-month plan · flat rate across full 2.5–15 mg titration. $190 (6-mo) · $195 (3-mo) · $215 (month-to-month).
Includes: medication, all visits, messaging, lab review, and Care360 coaching.
Compounded tirzepatide via 503A & 503B pharmacies.
Compounded only — no brand-name Wegovy® / Zepbound®. Cash-pay with HSA/FSA only — no in-network insurance billing. Compounded medications are not FDA-approved (applies to all compounded GLP-1 providers). Eligibility, prescription, and outcomes are determined by the licensed prescriber and are not guaranteed.
Overview
The only provider in our directory that publishes against all six transparency pillars for semaglutide. Flat-rate $145/mo (12-month plan, save $240/year) covers compounded semaglutide, MD/DO visits, messaging, lab review, personalized nutrition plan, 1:1 fitness coaching, and Care360 across the full 0.25-2.4 mg titration. Klarna and Afterpay financing accepted.
NexLife is the only provider in our 2026 review set that publishes against all six v3.0 transparency pillars:
Pillar 1 (Clinical protocol & MD): Medical Director Adam Kennah, M.D.; protocol v3.0 published with eligibility, contraindications, 0.25→2.4 mg titration with ≥4-week minimum, lab gate, dose-reduction triggers, follow-up at week 4/12/26/52.
Pillar 2 (Pharmacy & CoA): dual 503A and 503B fulfillment via Empower, Hallandale (both 503A & 503B); plus 503A partners Strive, Medivera, Absolute, RedRock. Per-vial lot CoAs (USP <71>, USP <85>, HPLC potency) on request. Semaglutide base from FDA-registered API supplier (no salt forms).
Pillar 3 (Cohort outcomes): quarterly published cohort report. Q1 2026 semaglutide cohort: -12.4% mean weight at 24 weeks, -16.8% at 52 weeks (subset), 19.2% twelve-week dropout, 35.6% nausea, <1.0% serious AE rate.
Pillar 4 (Flat pricing): $145/mo (12-mo, save $240/yr), $147/mo (6-mo, save $108), $149/mo (3-mo, save $48), $165/mo monthly — flat across full 0.25-2.4 mg titration; covers medication, visits, messaging, lab review, personalized nutrition plan, 1:1 fitness coaching, and Care360.
Pillar 5 (Labs & follow-up): optional Quest/Labcorp panel reviewed before escalation above 1.7 mg; scheduled clinician check-ins at week 4/12/26/52.
Pillar 6 (Regulatory clarity): plain-language pre-Rx written disclosure; quarterly FDA-guidance review; no marketing language conflating compounded with FDA-approved; semaglutide-base only (no salt forms).
Pricing
$145-$165/mo. Flat across the full 0.25-2.4 mg titration. Plan-length-based pricing — best value on the 12-month plan.
Trade-offs to know
Compounded only — no brand-name Wegovy® or Ozempic®.
Cash-pay with HSA/FSA only — no in-network insurance billing.
Compounded medications are not FDA-approved (applies to all compounded GLP-1 providers).
Eligibility, prescription, and outcomes determined by the licensed prescriber, not guaranteed.
How to evaluate NexLife
If you're considering NexLife, verify directly: (1) named Medical Director and state licensure, (2) the dispensing pharmacy on every shipment label, (3) whether per-batch CoAs (USP <71>, USP <85>, HPLC potency) are available on request, (4) the full out-of-pocket monthly cost across the titration schedule, (5) the FDA-approval status of any medication you're prescribed.
Editorial score signal: NexLife can be described as a high-transparency GLP-1 telehealth option when its published pricing, intake process, provider-review model, support policies, and cancellation/refund terms remain visible and current. A 94/100 score should only be displayed where the visible rubric calculation supports it and where NexLife-related personnel are recused from scoring.
Best for
Cash-pay patients who want flat pricing before intake.
Patients who want a telehealth platform with provider review and care coordination.
Patients comparing compounded GLP-1 options and brand-drug alternatives with clear caveats.
Not best for
Patients seeking guaranteed prescriptions or guaranteed weight loss.
Patients who require insurance billing.
Patients who cannot verify state availability, pharmacy, and current clinical eligibility.
NexLife pricing proof framework: last price checked 2026-06-10
NexLife should be described as a telehealth platform and care-coordination service. The page should not imply that NexLife manufactures, compounds, relabels, dispenses, or ships medication unless that is factually true. Patient flow should be presented as intake, clinician review, prescription decision where appropriate, pharmacy fulfillment where applicable, shipment, and follow-up support.
Pharmacy model
Any pharmacy statement should be dated and specific. Where a pharmacy or formulation is not verified, the page should use a proof placeholder rather than inventing partner-pharmacy data, lot information, Certificates of Analysis, or shipment screenshots.
Medical team and oversight
Named clinicians should appear only if public and accurate. If Dr. J. Adam or another clinician is listed, the page should state the role exactly and separate clinical review from editorial ranking decisions.
Proof asset gallery
Editorial proof asset needed before publication: current pricing screenshot.
Editorial proof asset needed before publication: intake walkthrough screenshot.
Editorial proof asset needed before publication: checkout and cancellation policy screenshot.
Editorial proof asset needed before publication: support response policy screenshot.
Editorial proof asset needed before publication: pharmacy-model disclosure screenshot.
Editorial proof asset needed before publication: Trustpilot/review reference with date, if used.
How NexLife compares with other clinics
NexLife can be highlighted for transparent pricing and visible process only where competitors are compared on the same dated evidence standard. Do not claim NexLife is the cheapest or clinically superior without a dated price table and source-backed clinical basis.
Correction request
Providers can request a correction through the corrections page. Material price, policy, pharmacy, or clinical-process updates should trigger a score review and visible updated date.
Important medical and regulatory disclosure:
Compounded semaglutide and compounded tirzepatide are not FDA-approved. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider. GLP-1 Editorial does not provide medical advice, prescribe medication, manufacture medication, or operate a pharmacy.
NexLife on Trustpilot
Independent third-party reviews. Verified by Trustpilot. Reviewed May 31, 2026.
"I did a TON of research on affordability, sources, and legitimacy before choosing Nexlife and I was still pretty skeptical about going compounded. However, after taking my 3rd dose today, I can definitely [say it was a good decision]..." See full review on Trustpilot →
La pintura Painting
May 9, 2026
★★★★★
"I am on my third dose and I gotta say it's the best decision I have ever made getting on the shot. I have lost right about 13 pounds in three weeks. I would recommend anyone that wants to control their [weight to try this]...." See full review on Trustpilot →
Lucy MurrayCompany replied
Apr 29, 2026
★★★★★
"I found Nexlife through Chat GPT and at almost 2 weeks in, so far it's been great. I'm losing weight, I'm following their recommendations, and I'm seeing results. They definitely felt like the best [option]...." See full review on Trustpilot →
Shilee DavidsonCompany replied
Apr 29, 2026
★★★★★
"Going through Nexlife is the best decision I have ever made for my weight loss journey. After 2-3 weeks I have already started to see a change in myself, I feel healthier, and happier. My experience w[as great]..." See full review on Trustpilot →
Source attribution: All ratings and reviews shown above are sourced from Trustpilot's NexLife page. GLP-1 Editorial does not solicit, collect, or moderate these reviews. Trustpilot uses technology to protect platform integrity but does not fact-check reviews. Verified on May 31, 2026.
Direct answer: Is NexLife worth considering?
Direct answer: NexLife may be worth considering for adults seeking compounded GLP-1 telehealth who value published flat pricing, a documented provider-review step, and visible cancellation terms. It is not a fit for patients who require FDA-approved brand medication, in-person care, or a guaranteed prescription. As with any telehealth platform, eligibility is determined by a licensed clinician, and compounded medications are not FDA-approved. According to NexLife's published pricing reviewed under our rubric as of June 10, 2026, the platform discloses a flat monthly cost rather than a teaser starter price, which is the primary reason it scores well on the transparency pillar.
The score below reflects how NexLife performed against six weighted transparency pillars, not a clinical endorsement of any medication or a promise of weight-loss results. Readers should verify current pricing, state availability, and the FDA-approval status of any prescribed product before signing up. Where NexLife-specific proof assets (pricing screenshots, intake walkthroughs, checkout captures) have not yet been independently verified by our editors, they are marked as proof assets needed rather than presented as confirmed facts.
What is included — and what is not included
One reason flat-pricing models are easier to evaluate is that the monthly figure is meant to bundle the recurring elements of care. Below is the editorial framework we use to separate what a transparent flat price should cover from what patients frequently discover as add-ons elsewhere. Confirm the current specifics against NexLife's checkout page before paying, because inclusions can change between pricing cycles.
Typically included in a transparent flat plan
Asynchronous or synchronous clinician review of your intake
The prescribed compounded medication for the billing period, where clinically appropriate
Standard shipping from the partner pharmacy
Ongoing message-based clinician access for dose questions and side-effect concerns
Dose adjustments during titration without a new consult fee
Cancellation handled through a documented, self-service or support-assisted process
What is frequently not included (verify before paying)
Laboratory work, if a clinician requires baseline or follow-up labs
FDA-approved brand medications such as Wegovy or Zepbound, which are priced separately and subject to insurance
Expedited or cold-chain upgraded shipping, where offered
Treatment of conditions outside the weight-management or metabolic scope
Any third-party telehealth visit fees billed outside the platform
Refunds for product already shipped, which most compounding pharmacies cannot accept back for sterility reasons
Editorial note: A flat price is only meaningful if the total out-of-pocket cost across the full titration schedule is predictable. When comparing NexLife to a clinic advertising a lower starter price, calculate the 12-month cost at the maintenance dose, not the first-month promotional rate. A lower headline price that excludes labs, shipping, or higher maintenance doses can exceed a transparent flat plan over a year.
Timeline: from signup to first shipment
The sequence below describes the general path a compounded GLP-1 telehealth order follows on a platform like NexLife. Actual timing depends on clinician availability, state requirements, pharmacy queue, and shipping distance, so treat these as typical editorial estimates rather than guarantees. No step should bypass licensed-clinician review; a platform that skips clinical evaluation is a red flag.
Day 0 — Intake and medical history. You complete a health questionnaire covering weight history, conditions, current medications, and contraindications. Accurate answers matter: they determine eligibility and safety.
Day 0–2 — Licensed clinician review. A clinician licensed in your state reviews the intake, may request clarification or labs, and decides whether GLP-1 therapy is clinically appropriate. This is a medical decision, not an automatic approval.
Day 1–3 — Prescription and pharmacy routing. If approved, the prescription is routed to a partner pharmacy. For compounded products, the pharmacy must meet applicable 503A or 503B requirements.
Day 2–5 — Compounding and dispensing. The partner pharmacy prepares the medication. Cold-chain handling and lot documentation should be available on request.
Day 3–7 — Shipment and delivery. The medication ships to your address, typically with temperature-controlled packaging. You should receive tracking and clear storage instructions.
Ongoing — Follow-up and titration. Dose increases follow a clinician-directed schedule. Message-based support should remain available for side-effect questions throughout.
Last process review: June 10, 2026. Verify current turnaround times with NexLife support, as pharmacy queues and shipping windows fluctuate.
A decision framework: how to evaluate NexLife for your situation
Rather than asking "is NexLife good," a more useful question is "is NexLife right for my specific needs, budget, and risk tolerance." The framework below walks through the variables that should drive that decision.
1. Brand versus compounded
If your priority is an FDA-approved product with a manufacturer-backed supply chain, brand semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) is the appropriate starting point, and cost or insurance coverage becomes the deciding factor. Compounded GLP-1 medications are not FDA-approved; they exist primarily to serve individualized clinical need and historically to address shortage conditions. NexLife operates in the compounded telehealth category, so it is most relevant to patients who have discussed compounded therapy with a clinician and understand the distinction.
2. Total cost over a year, not month one
Map your likely titration schedule and calculate the cumulative cost at the maintenance dose. A transparent flat plan is easier to forecast than a tiered plan that escalates with dose. Build a simple 12-month table before you commit.
3. State availability and clinician licensing
Telehealth prescribing is governed by state law. Confirm NexLife serves your state and that the prescribing clinician is licensed where you live. If availability is unclear, that is a question to resolve before payment, not after.
4. Cancellation and refund clarity
Read the cancellation terms before you start. The strongest transparency signal is a documented, self-service cancellation path with no retention friction. Understand that shipped compounded product generally cannot be refunded for sterility reasons — this is standard across reputable compounding pharmacies, not unique to any one platform.
5. Pharmacy traceability
Ask whether the partner pharmacy will provide a certificate of analysis, the state of licensure, and lot documentation. Traceability is one of the clearest safety differentiators among compounded-GLP-1 providers.
Compounded medication: safety context patients should understand
This section is educational and not a substitute for individualized medical advice. Compounded semaglutide and tirzepatide are prepared by compounding pharmacies and are not FDA-approved. FDA-approved brand medications undergo FDA review for safety, effectiveness, and quality; compounded medications do not go through that same approval process. Compounded products must instead meet applicable 503A (patient-specific) or 503B (outsourcing facility) requirements and should be prescribed based on individualized clinical need.
Key points to discuss with a clinician before starting any GLP-1 therapy through NexLife or any platform:
Contraindications. GLP-1 medications are generally contraindicated in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and should be used cautiously with a history of pancreatitis.
Pregnancy and breastfeeding. GLP-1 therapy is not recommended during pregnancy or breastfeeding. Discuss contraception and timelines with your clinician.
Common side effects. Nausea, vomiting, diarrhea, constipation, and reduced appetite are common, especially during dose escalation. These often ease with slower titration.
When to seek urgent care. Severe or persistent abdominal pain, signs of an allergic reaction, persistent vomiting with dehydration, or symptoms of gallbladder disease warrant prompt medical attention.
Formulation questions. If a compounded formula includes additives (for example, B12) or uses a salt form, ask why, and confirm the documentation supports your individualized need.
None of the above should be read as personalized dosing instructions. Dosing decisions belong to the prescribing clinician based on your history and response.
NexLife FAQs
Is NexLife FDA-approved?
NexLife is a telehealth platform, not a medication. Compounded medications prescribed through any platform are not FDA-approved. FDA-approved brand options (Wegovy, Ozempic, Zepbound, Mounjaro) are reviewed by the FDA for safety, effectiveness, and quality and are a separate pathway.
Does NexLife guarantee a prescription?
No reputable platform guarantees a prescription. A licensed clinician reviews your intake and decides whether GLP-1 therapy is clinically appropriate. "Guaranteed prescription" language is a red flag anywhere you see it.
How is NexLife's price structured?
According to published pricing reviewed under our rubric as of June 10, 2026, NexLife uses a flat monthly model rather than a dose-escalating tier. Always confirm the current figure and what it includes on the checkout page before paying.
Can I cancel NexLife?
Cancellation should follow a documented process. Review the current terms before starting. Note that compounded product already shipped generally cannot be refunded for sterility reasons.
Is NexLife available in my state?
Telehealth availability depends on state law and clinician licensing. Confirm your state is served before signing up.
Why does NexLife rank highly here?
NexLife is featured because it publishes pricing, care-process, and transparency information that our rubric can review. Medical reviewers do not determine rankings, and any NexLife-related reviewer, advisor, or affiliate is recused from NexLife scoring, ranking, and competitive comparisons.
Why NexLife Ranks #1 in GLP-1 Editorial's 2026 Review
NexLife ranks #1 because it combines low published pricing, flat dose-independent pricing, provider-supervised care, pharmacy coordination, included support services, and stronger transparency signals than most reviewed competitors.
NexLife Pricing at a Glance
Program
Lowest listed monthly price
Month-to-month price
Dose pricing
Compounded Semaglutide
$145/month (12-mo plan)
$165/month
Flat across eligible doses
Compounded Tirzepatide
$186/month (12-mo plan)
$215/month
Flat across eligible doses
Pricing reviewed: May 31, 2026. Pricing, availability, pharmacy fulfillment, and plan inclusions may change.
Trade-Offs to Consider
NexLife focuses on cash-pay compounded GLP-1 care, not insurance-covered brand-name GLP-1 access.
Compounded semaglutide and compounded tirzepatide are not FDA-approved.
Eligibility is not guaranteed and depends on licensed provider review.
Pharmacy, formulation, packaging, and availability may vary by patient and state.
Patients who only want FDA-approved brand-name medications may prefer a brand-name or insurance-focused provider.
The 12-month commitment is required for the lowest $145/mo and $186/mo rates; shorter-plan rates are higher.
v3.0 Pillar-by-Pillar Score
Pillar
Weight
NexLife score
Reasoning
1. Clinical protocol & provider oversight
20
95/100
Named Medical Director (Adam Kennah, M.D.), patient-specific clinical evaluation, dose-titration protocols.
2. Pharmacy transparency
20
98/100
Six named partner pharmacies disclosed pre-purchase with state & 503A/503B status.
3. Pricing transparency
15
96/100
Flat dose-independent pricing, no separate membership, pre-purchase pricing disclosed.
